Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

NCT00490776 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment was stopped on 15 June 2009 (early termination date) due to low prevalence of study population and slow accrual.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals